Acadia Pharmaceuticals buy BMO Capital Markets
Start price
21.07.26
/
50%
€22.30
Target price
21.07.27
€31.55
Performance (%)
-0.90%
Price
15:46
€22.10
Summary
This prediction is currently active. Since the start of the prediction for Acadia Pharmaceuticals the price has only changed by -0.90%. This prediction currently runs until 21.07.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Acadia Pharmaceuticals | -0.90% |
| iShares Core DAX® | 0.073% |
| iShares Nasdaq 100 | -1.344% |
| iShares Nikkei 225® | -2.314% |
| iShares S&P 500 | -0.340% |
Comments by BMO_Capital_Markets for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (ACAD) had its price target raised by BMO Capital Markets from $34.00 to $36.00. They now have an "outperform" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.41
19.05.25
19.05.25
€25.05
19.05.26
19.05.26
-9.74%
20.05.26
20.05.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€15.27
27.06.24
27.06.24
€28.91
27.06.25
27.06.25
23.25%
28.06.25
28.06.25